Top Back to top

Donor lymphocyte infusions after haploidentical stem cell transplantation: a study on behalf of the cellular therapy & immunobiology working party of the EBMT

Cellular Therapy & Immunobiology Working Party (CTIWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Short title:
DLI after haplo-HSCT
Primary objective:
Key inclusion criteria:
Adults (⩾18 years) with hematological malignancies who received DLI post T replete haplo-SCT in EBMT transplant centres from 2007 to 2017.
Principal investigator:
Nicole Santoro
EBMT Study coordinator:
Jorinde Hoogenboom
Study coordinator email: